We are committed to helping our portfolio companies succeed
Our leading CRO platform is productive and efficient and it enables both quick and quality drug candidate discovery
Later Stage Funding Introductions
VBI can serve as a source of future connections and financing through our ever-growing network and syndicate of investors throughout China and the US.
Support from Venture Partners & Business Partners
Portfolio companies enjoy extensive support from VBI’s Venture Partners who are all senior scientists, industry specialists, and fellow biotech entrepreneurs. Founders can also receive business and management assistance from seasoned experts.
VBI can assist with the distribution of news and updates to help facilitate future financing and outreach.
VBI’s wealth of experience helps us to work with our portfolio companies so they can remain on track and within their budgets while being able to pull in new sources of funding.
Lab and office locations in Shanghai, Jiaxing, Chengdu, Hangzhou, Boston, San Diego, etc.
“Back-office” support (HR, Accounting, Procurement, BD, Financing, etc.)
Focusing on therapeutic development to treat the root cause of hyperuricemia and gout The AR882(for Hyperuricemia and gout) is on the Phase 1 Australia, Phase 1 US and Phase 2 New Zealand.MORE >
“Viva BioInnovator is truly a value-added investor. They have facilitated introductions to numerous investors and provided forums to showcase DTx Pharma technology to potential investors and partners.“MORE >
"Viva BioInnovator is one of the few which really understand the challenges early startups face and the opportunities they can bring. VBI values the technology and innovation and has the eye to spot them. What’s equally valuable are the ecosystem which VMORE >
Leader of innovative topical medication, focusing to becoming global first-in-class drug discovery company in ophthalmology and dermatology.MORE >